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INTRODUCTION 
To get speedy recovery from any deadly diseases, the most 
important thing is getting proper medication1-9. In the 
passing years, it has been seen that cells and specific genes in 
the human body are acquiring drug resistance capability 
against certain drugs which needs to work correctly for 
getting rid of any particular diseases. Therefore, the 
introduction of nanoparticle and exosomes are gaining 
importance in drug manufacturing units. It is not only 
helping the drug get administered into the exact position 
where it needs to get delivered but also hastening speedy 
recovery of the patient from a lethal disease10-19.  
Numerous methods are used to get rid of the problem like 
drug resistance ability, impassability of drugs through 
intercellular pathways and gene silencing activities.  
It has been seen that few specific cancers like glioblastoma 
are more robust to get diagnosed in the initial stages. Hence, 
during the final stages, it becomes impossible for 
chemotherapeutic drugs to get administered into the exact 
location of the disease.  
Nanoparticles are used in this regard for early detection and 
treatment of such specific brain tumor cases20-31. Apart from 
that, exosomes, as extracellular organelles can be used to get 
proteomic and genetic information from long distance 
intercellular communication. Along with it, exosomes are 
used for proper drug delivery on the exact location where 
the disease is mainly predominant.  
Similarly, psychosis is another fatal disease that is impacting 
thousands of people worldwide. Nanoparticles are used for 
the treatment of this disease for delivering the drug. 
Nanoparticles of 1-500 nanometers are used primarily to 
administer antipsychotic drugs into the human body so that 
the administered drugs can get easily absorbed through the 
blood-brain barrier32-44.    
To control the impact of multidrug resistance among the 
human sometimes excessive amount of drugs get 
administered, but it only causes intolerance of toxicity and 
death of the patient. Along with it, histone modification and 
DNA methylation have been introduced to minimize the 
issues in this regards. Synthesis of oligonucleotides after 
some chemical modification and synthesis of some nano-
sized camptothecin for combined drug delivery are also few 
steps that are getting followed. Doxorubicin (DOX) is the best 
medication used for curing the malignant tumor. Apart from 
that, lung and cervical carcinomas T7 peptide conjugated 
nanoparticles are mainly used. 
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Table 1: Nanoparticles with Dual Drug Delivery to Control MDR 
 
  
 
Figure 2: Chemical Structure of DOX 
 
Different strategies and process have been invented for 
careful drug delivery into the affected areas. To control the 
multi-drug resistance (MDR), the process to introduce 
multiple chemotherapeutic drugs is used nowadays. Apart 
from this, nanoparticles used for antipsychotic disease 
treatment is comparatively low while it is mainly used for 
cancer treatment45-51. This is only for the lack of knowledge 
about psychosis that restricts the drugs from being designed. 
Similarly, safe designing of the EMs cell for gene therapy is 
used for the proper treatment of cancer cells of the human 
body. On the other hand, DNA methylation represses the 
growth and spread of cancer cell for the long term. Non-
small-cell lung cancer (NSCLC) is a lethal form of lung cancer 
that accounts for 80% of total lung cancer cases around the 
world. NSCLC is less responsive for chemotherapy, 
radiotherapy and any treatment.  
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